Somerset Therapeutics dexamethasone injection recalled for impurity levels
What this means
Somerset Therapeutics is recalling one lot of dexamethasone sodium phosphate injection because testing found impurity levels above acceptable limits as the product approached its expiration date. The affected lot (A240421, expiring 07/31/2026) was distributed nationwide. No injuries have been reported.
- Check your facility's inventory for lot A240421 of Somerset Therapeutics dexamethasone sodium phosphate injection (NDC 70069-025-01 or 70069-025-10)
- Do not use vials from this lot
- Contact Somerset Therapeutics or your supplier for return or disposal instructions
- Consult your pharmacist or healthcare provider if you have questions
The agency's original wording
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0398-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.